loadpatents
Patent applications and USPTO patent grants for YAMASAKI; Motoo.The latest application filed is for "long-acting adrenomedullin derivative".
Patent | Date |
---|---|
Long-acting Adrenomedullin Derivative App 20210115103 - KITAMURA; Kazuo ;   et al. | 2021-04-22 |
Long-acting Adrenomedullin Derivative App 20210008219 - Kitamura; Kazuo ;   et al. | 2021-01-14 |
Long-acting adrenomedullin derivative Grant 10,842,879 - Kitamura , et al. November 24, 2 | 2020-11-24 |
Method Of Producing Antibodies With N-glycoside-linked Sugar Chains Lacking Fucosylation App 20200017593 - HANAI; Nobuo ;   et al. | 2020-01-16 |
Antibody Composition-producing Cell App 20190360015 - Kanda; Yutaka ;   et al. | 2019-11-28 |
Antibody and antibody fragment introduced new modification sites Grant 10,233,246 - Yamasaki , et al. | 2019-03-19 |
Antibody composition-producing cell Grant 10,233,475 - Kanda , et al. | 2019-03-19 |
Method of modulating the activity of functional immune molecules Grant 10,233,247 - Hanai , et al. | 2019-03-19 |
Long-acting Adrenomedullin Derivative App 20180264123 - Kitamura; Kazuo ;   et al. | 2018-09-20 |
Method Of Modulating The Activity Of Functional Immune Molecules App 20170240647 - HANAI; Nobuo ;   et al. | 2017-08-24 |
Antibody Composition-producing Cell App 20160348145 - KANDA; Yutaka ;   et al. | 2016-12-01 |
Antibody composition-producing cell Grant 9,409,982 - Kanda , et al. August 9, 2 | 2016-08-09 |
Novel Antibody And Antibody Fragment Introduced New Modification Sites App 20160039937 - YAMASAKI; Motoo ;   et al. | 2016-02-11 |
Antibody and antibody fragment introduced new modification sites Grant 9,150,639 - Yamasaki , et al. October 6, 2 | 2015-10-06 |
Antibody Composition-producing Cell App 20150112046 - KANDA; Yutaka ;   et al. | 2015-04-23 |
Antibody composition-producing cell Grant 8,895,266 - Kanda , et al. November 25, 2 | 2014-11-25 |
Method Of Modulating The Activity Of Functional Immune Molecules App 20140234300 - HANAI; Nobuo ;   et al. | 2014-08-21 |
Method of modulating the activity of functional immune molecules Grant 8,679,491 - Hanai , et al. March 25, 2 | 2014-03-25 |
Method for producing recombinant antibody and antibody fragment thereof Grant 8,632,996 - Shitara , et al. January 21, 2 | 2014-01-21 |
Antibody Composition-producing Cell App 20130189736 - KANDA; Yutaka ;   et al. | 2013-07-25 |
Cells with altered fucosylation and producing antibodies therefrom Grant 8,367,407 - Kanda , et al. February 5, 2 | 2013-02-05 |
Antibody composition-producing cell Grant 8,329,443 - Kanda , et al. December 11, 2 | 2012-12-11 |
Gene Recombinant Antibody And Antibody Fragment Thereof App 20120276090 - SHITARA; Kenya ;   et al. | 2012-11-01 |
Method for treating the Th2-mediated disease Grant 8,197,814 - Shitara , et al. June 12, 2 | 2012-06-12 |
Glycoengineered, recombinant antibody Grant 8,158,760 - Kanda , et al. April 17, 2 | 2012-04-17 |
Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody Grant 8,110,195 - Kanda , et al. February 7, 2 | 2012-02-07 |
Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation Grant 8,101,185 - Kanda , et al. January 24, 2 | 2012-01-24 |
Novel Antibody And Antibody Fragment Introduced New Modification Sites App 20120009621 - YAMASAKI; Motoo ;   et al. | 2012-01-12 |
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase Grant 8,067,232 - Kanda , et al. November 29, 2 | 2011-11-29 |
Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation Grant 8,039,595 - Kanda , et al. October 18, 2 | 2011-10-18 |
Antibody Composition-producing Cell App 20110250643 - KANDA; Yutaka ;   et al. | 2011-10-13 |
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110059115 - KANDA; YUTAKA ;   et al. | 2011-03-10 |
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110052610 - Kanda; Yutaka ;   et al. | 2011-03-03 |
Antibody Composition Exhibiting Cellular Cytotoxicty Due To Glycosylation App 20110027271 - KANDA; Yutaka ;   et al. | 2011-02-03 |
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi Grant 7,846,725 - Kanda , et al. December 7, 2 | 2010-12-07 |
Novel Peptides App 20100248255 - Yamasaki; Motoo ;   et al. | 2010-09-30 |
Method for Treating the TH2-Mediated Disease App 20100221178 - SHITARA; Kenya ;   et al. | 2010-09-02 |
Method Of Modulating The Activity Of Functional Immune Molecules App 20100196371 - HANAI; NOBUO ;   et al. | 2010-08-05 |
Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor Grant 7,763,246 - Hanai , et al. July 27, 2 | 2010-07-27 |
Compound Modified With Glycerol Derivative App 20100172967 - Nemoto; Hisao ;   et al. | 2010-07-08 |
Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation Grant 7,741,442 - Kanda , et al. June 22, 2 | 2010-06-22 |
Antibody composition-producing cell Grant 7,737,325 - Kanda , et al. June 15, 2 | 2010-06-15 |
Antibody Composition-Producing Cell App 20100143388 - KANDA; YUTAKA ;   et al. | 2010-06-10 |
Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein Grant 7,718,175 - Hanai , et al. May 18, 2 | 2010-05-18 |
Methods for producing antibody compositions with increased ADCC Grant 7,708,992 - Hanai , et al. May 4, 2 | 2010-05-04 |
Method of modulating the activity of functional immune molecules Grant 7,708,997 - Hanai , et al. May 4, 2 | 2010-05-04 |
Compound modified with glycerol derivative Grant 7,696,359 - Nemoto , et al. April 13, 2 | 2010-04-13 |
Branched polyalkylene glycols Grant 7,691,367 - Yamasaki , et al. April 6, 2 | 2010-04-06 |
Method of modulating the activity of functional immune molecules to Her-2 Grant 7,687,061 - Hanai , et al. March 30, 2 | 2010-03-30 |
Novel Peptides App 20100075343 - Yamasaki; Motoo ;   et al. | 2010-03-25 |
Method of modulating the activity of functional immune molecules Grant 7,682,610 - Hanai , et al. March 23, 2 | 2010-03-23 |
Method of modulating the activity of functional immune molecules to CXCR4 protein Grant 7,682,611 - Hanai , et al. March 23, 2 | 2010-03-23 |
Method for treating Th2-mediated disease Grant 7,666,418 - Shitara , et al. February 23, 2 | 2010-02-23 |
Method of modulating the activity of functional immune molecules to GM2 Grant 7,655,228 - Hanai , et al. February 2, 2 | 2010-02-02 |
Method of modulating the activity of functional immune molecules to CD52 Grant 7,651,688 - Hanai , et al. January 26, 2 | 2010-01-26 |
Platelet production promoting agent Grant 7,592,311 - Yamasaki , et al. September 22, 2 | 2009-09-22 |
Antibody Composition-Producing Cell App 20090228994 - KANDA; Yutaka ;   et al. | 2009-09-10 |
Glycerol derivative Grant 7,569,706 - Nemoto , et al. August 4, 2 | 2009-08-04 |
Glycoengineered, Recombinant Antibody App 20090191592 - KANDA; Yutaka ;   et al. | 2009-07-30 |
Glycoengineered, Recombinant Antibody App 20090191199 - KANDA; Yutaka ;   et al. | 2009-07-30 |
Branched polyalkylene glycols Grant 7,547,765 - Yamasaki , et al. June 16, 2 | 2009-06-16 |
Chemically modified polypeptides Grant 7,547,675 - Yamasaki , et al. June 16, 2 | 2009-06-16 |
Antibody Composition-Producing Cell App 20080261301 - Kanda; Yutaka ;   et al. | 2008-10-23 |
Antibody Composition-Producing Cell App 20080227196 - Kanda; Yutaka ;   et al. | 2008-09-18 |
Antibody composition-producing cell Grant 7,425,446 - Kanda , et al. September 16, 2 | 2008-09-16 |
Method of Modulating the Activity of Functional Immune Molecules App 20080177043 - Hanai; Nobuo ;   et al. | 2008-07-24 |
Mammalian host cell modified by RNAi to inhibit .alpha. 1,6-fucosyltransferase Grant 7,393,683 - Kanda , et al. July 1, 2 | 2008-07-01 |
Branched Polyalkylene Glycols App 20080125350 - Yamasaki; Motoo ;   et al. | 2008-05-29 |
Branched polyalkylene glycols Grant 7,291,713 - Yamasaki , et al. November 6, 2 | 2007-11-06 |
Method of Modulating the Activity of Functional Immune Molecules App 20070207151 - Hanai; Nobuo ;   et al. | 2007-09-06 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166305 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166303 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166300 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166304 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166302 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Method of Modulating the Activity of Functional Immune Molecules App 20070166301 - Hanai; Nobuo ;   et al. | 2007-07-19 |
Anti-fibroblast growth factor-8 monoclonal antibody Grant 7,241,568 - Hanai , et al. July 10, 2 | 2007-07-10 |
Method of modulating the activity of functional immune molecules Grant 7,214,775 - Hanai , et al. May 8, 2 | 2007-05-08 |
Antibody Composition-Producing Cell App 20070010009 - Kanda; Yutaka ;   et al. | 2007-01-11 |
Compound modified with glycerol derivative App 20060280784 - Nemoto; Hisao ;   et al. | 2006-12-14 |
Process for purifying antibody Grant 7,064,191 - Shinkawa , et al. June 20, 2 | 2006-06-20 |
Antibody composition-producing cell App 20060078990 - Kanda; Yutaka ;   et al. | 2006-04-13 |
Antibody composition-producing cell App 20060078991 - Kanda; Yutaka ;   et al. | 2006-04-13 |
Antibody composition-producing cell App 20060064781 - Kanda; Yutaka ;   et al. | 2006-03-23 |
Antibody composition-producing cell App 20060063254 - Kanda; Yutaka ;   et al. | 2006-03-23 |
Platelet production promoting agent App 20060040865 - Yamasaki; Motoo ;   et al. | 2006-02-23 |
Method of modulating the activity of functional immune molecules App 20060024800 - Hanai; Nobuo ;   et al. | 2006-02-02 |
Recombinant antibody and antibody fragment Grant 6,989,145 - Shitara , et al. January 24, 2 | 2006-01-24 |
Method of modulating the activity of functional immune molecules App 20050276805 - Hanai, Nobuo ;   et al. | 2005-12-15 |
Method of modulating the activity of functional immune molecules App 20050272916 - Hanai, Nobuo ;   et al. | 2005-12-08 |
Antibody composition-producing cell App 20050262593 - Kanda, Yutaka ;   et al. | 2005-11-24 |
Glycerol derivative App 20050208015 - Nemoto, Hisao ;   et al. | 2005-09-22 |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity Grant 6,946,292 - Kanda , et al. September 20, 2 | 2005-09-20 |
Method for treating Th2-mediated disease App 20050187380 - Shitara, Kenya ;   et al. | 2005-08-25 |
E2F activity-inhibiting compound App 20050137138 - Shibata, Kenji ;   et al. | 2005-06-23 |
hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same Grant 6,884,419 - Yokoi , et al. April 26, 2 | 2005-04-26 |
Peptides Grant 6,872,803 - Shibata , et al. March 29, 2 | 2005-03-29 |
Branched polyalkylene glycols App 20050063936 - Yamasaki, Motoo ;   et al. | 2005-03-24 |
Monoclonal antibody for human telomerase catalytic subunit App 20040219667 - Hanai, Nobuo ;   et al. | 2004-11-04 |
Anti-fibroblast growth factor-8 monoclonal antibody App 20040091480 - Hanai, Nobuo ;   et al. | 2004-05-13 |
E2F activity inhibitory compounds Grant 6,713,449 - Shibata , et al. March 30, 2 | 2004-03-30 |
Branched polyalkylene glycols App 20030219404 - Yamasaki, Motoo ;   et al. | 2003-11-27 |
Endothelin-antagonizing peptide Grant 6,642,355 - Tanaka , et al. November 4, 2 | 2003-11-04 |
Toxin conjugates Grant 6,638,509 - Suzawa , et al. October 28, 2 | 2003-10-28 |
Monoclonal antibody against human telomerase catalytic subunit Grant 6,639,057 - Hanai , et al. October 28, 2 | 2003-10-28 |
Chemically modified polypeptides App 20030195339 - Yamasaki, Motoo ;   et al. | 2003-10-16 |
Antibody composition-producing cell App 20030115614 - Kanda, Yutaka ;   et al. | 2003-06-19 |
Endothelin-antagonizing peptide App 20030055213 - Tanaka, Takeo ;   et al. | 2003-03-20 |
Peptides Promoting The Activation Of Latent Tgf-beta And Method For Screening Tgf-beta Activity Regulators App 20030027218 - YAMASAKI, MOTOO ;   et al. | 2003-02-06 |
Method of separating and purifying protein App 20030023043 - Uchida, Kazuhisa ;   et al. | 2003-01-30 |
Process for purifying antibody App 20020164328 - Shinkawa, Toyohide ;   et al. | 2002-11-07 |
Gene recombinant antibody and antibody fragment thereof App 20020098527 - Shitara, Kenya ;   et al. | 2002-07-25 |
Anti-fibroblast growth factor-8 monoclonal antibody App 20020099181 - Hanai, Nobuo ;   et al. | 2002-07-25 |
Chemically Modified Polypeptides App 20020028912 - YAMASAKI, MOTOO ;   et al. | 2002-03-07 |
Platelet production promoting agent Grant 6,245,900 - Yamasaki , et al. June 12, 2 | 2001-06-12 |
Toxin conjugates Grant 6,103,236 - Suzawa , et al. August 15, 2 | 2000-08-15 |
G-CSF conjugate Grant 6,027,720 - Kuga , et al. February 22, 2 | 2000-02-22 |
Oxyntomodulin peptide having cardiotonic activity and insulin release-bromating activity Grant 5,858,975 - Yano , et al. January 12, 1 | 1999-01-12 |
Polypeptide derivatives of human granulocyte colony stimulating factor Grant 5,795,968 - Kuga , et al. August 18, 1 | 1998-08-18 |
Polypeptide derivatives of human granulocyte colony stimulating factor Grant 5,714,581 - Kuga , et al. February 3, 1 | 1998-02-03 |
DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide Grant 5,681,720 - Kuga , et al. October 28, 1 | 1997-10-28 |
Endothelin-antagonizing peptide Grant 5,639,860 - Tanaka , et al. June 17, 1 | 1997-06-17 |
Polypeptide derivatives of human granulocyte colony stimulating factor Grant 5,362,853 - Kuga , et al. November 8, 1 | 1994-11-08 |
Polypeptide derivatives of human granulocyte colony stimulating factor Grant 5,214,132 - Kuga , et al. May 25, 1 | 1993-05-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.